Tralokinumab as an Effective Alternative after Dupilumab Treatment Failure in Moderate-to-Severe Atopic Dermatitis: A Real-World Study. George SE, Yu J. J Am Acad Dermatol 2024 Aug 20:S0190-9622(24)02700.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

George SE, Yu J. Tralokinumab as an Effective Alternative after Dupilumab Treatment Failure in Moderate-to-Severe Atopic Dermatitis: A Real-World Study. J Am Acad Dermatol 2024 Aug 20:S0190-9622(24)02700.
PMID: 39173884